Antidiabetics Market Forecast: Industry Research Report

Antidiabetics Market Forecast

Published Date: October 2009

Published By: Datamonitor

Page Count: 125

Order Code: R313-55062

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Similar
Products

Introduction

Datamonitor expects the antidiabetics market to reach $38 billion, across the seven major markets, by 2018. The growth will be driven by the launch of new drug classes, notably the DPP-IV inhibitors and GLP-1 agonists, and large growth in patient numbers. However, patent expiries of the glitazone (TZDs) class will restrain market growth.

Reasons to Purchase

Quantify the future size of the antidiabetics market and identify opportunities for new products.
Learn how product expiries will shape the antidiabetics market.
Understand the barriers to uptake for novel antidiabetic agents, and the implications of recent regulatory reviews.

Please note: this is delivered as a Zip file.

Similar Products

• Snapshots US Pharmaceuticals 2009

Published Nov 2009 by Snapdata International Group

• Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis

Published Nov 2009 by Aruvian's R'search

• Pharmaceutical Industry in Mexico

Published Nov 2009 by Aruvian's R'search

• Pharmaceuticals Industry Report

Published Nov 2009 by Plimsoll Publishing Ltd.

• Antipsychotics Market Forecast

Published Oct 2009 by Datamonitor